Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 5
2013 5
2014 6
2015 2
2016 3
2017 6
2018 10
2019 9
2020 8
2021 8
2022 14
2023 1
2024 6
2025 7
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial.
Takuva S, Takalani A, Seocharan I, Yende-Zuma N, Reddy T, Engelbrecht I, Faesen M, Khuto K, Whyte C, Bailey V, Trivella V, Peter J, Opie J, Louw V, Rowji P, Jacobson B, Groenewald P, Dorrington RE, Laubscher R, Bradshaw D, Moultrie H, Fairall L, Sanne I, Gail-Bekker L, Gray G, Goga A, Garrett N; Sisonke study team. Takuva S, et al. Among authors: yende zuma n. PLoS Med. 2022 Jun 21;19(6):e1004024. doi: 10.1371/journal.pmed.1004024. eCollection 2022 Jun. PLoS Med. 2022. PMID: 35727802 Free PMC article. Clinical Trial.
Randomized trial of multi-strain Lactobacillus crispatus vaginal live biotherapeutic products after antibiotic therapy for bacterial vaginosis: study protocol for VIBRANT (vaginal lIve biotherapeutic RANdomized trial).
Chetty C, Mafunda N, Happel AU, Khan A, Cooley Demidkina B, Yende-Zuma N, Saidi Y, Mahabeer Polliah A, Lewis L, Osman F, Radebe P, Passmore JS, Kwon D, Ravel J, Ngcapu S, Liebenberg L, Symul L, Holmes S, Mitchell CM, Potloane D. Chetty C, et al. Among authors: yende zuma n. Contemp Clin Trials Commun. 2025 Sep 16;48:101554. doi: 10.1016/j.conctc.2025.101554. eCollection 2025 Dec. Contemp Clin Trials Commun. 2025. PMID: 41050878 Free PMC article.
Sustainability of task-shifting for antiretroviral treatment.
Naranbhai V, Karim QA, Naidoo K, Yende-Zuma N, Karim SS. Naranbhai V, et al. Among authors: yende zuma n. Lancet. 2012 Dec 1;380(9857):1907-8; author reply 1908. doi: 10.1016/S0140-6736(12)62110-2. Lancet. 2012. PMID: 23200500 Free PMC article. No abstract available.
Safety of a second homologous Ad26.COV2.S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa.
Takalani A, Robinson M, Jonas P, Bodenstein A, Sambo V, Jacobson B, Louw V, Opie J, Peter J, Rowji P, Seocharan I, Reddy T, Yende-Zuma N, Khutho K, Sanne I, Bekker LG, Gray G, Garrett N, Goga A; Sisonke Study Team. Takalani A, et al. Among authors: yende zuma n. Vaccine. 2024 Feb 27;42(6):1195-1199. doi: 10.1016/j.vaccine.2024.01.066. Epub 2024 Jan 25. Vaccine. 2024. PMID: 38278629 Clinical Trial.
A Mycobacterium tuberculosis Specific IgG3 Signature of Recurrent Tuberculosis.
Fischinger S, Cizmeci D, Shin S, Davies L, Grace PS, Sivro A, Yende-Zuma N, Streeck H, Fortune SM, Lauffenburger DA, Naidoo K, Alter G. Fischinger S, et al. Among authors: yende zuma n. Front Immunol. 2021 Sep 22;12:729186. doi: 10.3389/fimmu.2021.729186. eCollection 2021. Front Immunol. 2021. PMID: 34630406 Free PMC article.
86 results